Strain SummaryCBA/Rap

Strain Name

 CBA/Rap

Strain Type(s)

 inbred

Strain Synonym(s)

 CBA  •  CBA "Rappolovo" Animal Farm of the Russian Academy of Medical Sciences

Strain Links

 • Festing's List of Inbred Strains

Models

43 unique models displayed. A model is a set of tumors that share the same tumor name, organ(s) affected, and treatment type for a specific strain.
Frequency
Model Name Organ Affected Tumor Inducing Agent(s) Female Male Mixed Pop. Unspecified Additional Information Model Details
Blood vessel hemangioma Blood vessel

6.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Blood vessel hemangioma Blood vessel peptide Lys-Glu

2.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Blood vessel hemangioma Blood vessel peptide Ala-Glu-Asp-Gly

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Blood vessel hemangioma Liver

0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Blood vessel hemangioma Liver constant light

2.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Forestomach papilloma Forestomach

0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Forestomach papilloma Forestomach constant light

2.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Leukocyte leukemia Leukocyte

0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Leukocyte leukemia Leukocyte constant light

12

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Leukocyte lymphoma Leukocyte

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Leukocyte lymphoma Leukocyte peptide Lys-Glu

4.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Leukocyte lymphoma Leukocyte peptide Ala-Glu-Asp-Gly

4.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Liver hepatocellular carcinoma Liver

0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Liver hepatocellular carcinoma Liver constant light

8.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Lung adenocarcinoma Lung

0 - 2.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9   ⋅   Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Lung adenocarcinoma Lung peptide Lys-Glu

2.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Lung adenocarcinoma Lung peptide Ala-Glu-Asp-Gly

2.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Lung adenocarcinoma Lung constant light

14

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Lung adenoma Lung

2.0 - 20

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9   ⋅   Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Lung adenoma Lung peptide Lys-Glu

10

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Lung adenoma Lung peptide Ala-Glu-Asp-Gly

4.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Lung adenoma Lung constant light

2.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Mammary gland adenocarcinoma Mammary gland

2.0 - 6.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9   ⋅   Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Mammary gland adenocarcinoma Mammary gland peptide Lys-Glu

2.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Mammary gland adenocarcinoma Mammary gland peptide Ala-Glu-Asp-Gly

10

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Mammary gland adenocarcinoma Mammary gland constant light

4.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Sites of Metastasis: Lung
Mammary gland adenoma Mammary gland

2.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Mammary gland adenoma Mammary gland peptide Lys-Glu

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Mammary gland adenoma Mammary gland peptide Ala-Glu-Asp-Gly

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Mesodermal cell/mesoblast sarcoma - histiocytic fibrous Mesodermal cell/mesoblast

2.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Mesodermal cell/mesoblast sarcoma - histiocytic fibrous Mesodermal cell/mesoblast constant light

0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Muscle - Smooth leiomyosarcoma Uterus

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Muscle - Smooth leiomyosarcoma Uterus peptide Lys-Glu

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Muscle - Smooth leiomyosarcoma Uterus peptide Ala-Glu-Asp-Gly

2.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Skin - Epidermis - Basal cell carcinoma Skin - Epidermis - Basal cell

2.0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Skin - Epidermis - Basal cell carcinoma Skin - Epidermis - Basal cell constant light

0

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9

Skin papilloma Skin

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Skin papilloma Skin peptide Lys-Glu

2.0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

Skin papilloma Skin peptide Ala-Glu-Asp-Gly

0

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

(Unspecified organ) tumor (Unspecified organ)

8.0 - 30

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9   ⋅   Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

(Unspecified organ) tumor (Unspecified organ) peptide Lys-Glu

20

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

(Unspecified organ) tumor (Unspecified organ) peptide Ala-Glu-Asp-Gly

18

References: Anisimov VN, Mech Ageing Dev 2001 Jan;122(1):41-68

(Unspecified organ) tumor (Unspecified organ) constant light

30

References: Anisimov VN, Int J Cancer 2004 Sep 10;111(4):475-9